House dust mites as potential carriers for IgE sensitisation to bacterialantigens

Allergic Diseases

Comparison of bronchial and nasal allergen provocation in children and adolescents with bronchial asthma and house dust mite sensitization

Pediatr Allergy Immunol.

Fischl A, Eckrich J, Passlack V, Klenke S, Hartmann D, Herrmann E, Schulze J, Zielen S

doi: 10.1111/pai.13147.

Allergic Diseases

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens

Allergy.

Huang HJ, Curin M, Banerjee S, Chen KW, Garmatiuk T, Resch-Marat Y, Carvalho-Queiroz C, Blatt K, Gafvelin G, Grönlund H, Valent P, Campana R, Focke-Tejkl M, Valenta R, Vrtala S

doi: 10.1111/all.13956.

Allergic DiseasesImmunotherapyT Cells

Der p 1-specific regulatory T cell response during house dust mite allergen immunotherapy

Allergy.

Boonpiyathad T, Sokolowska M, Morita H, Rückert B, Kast JI, Wawrzyniak M, Sangasapaviliya A, Pradubpongsa P, Fuengthong R, Thantiworasit P, Sirivichayakul S, Kwok WW, Ruxrungtham K, Akdis M, Akdis CA

doi: 10.1111/all.13684.

Allergic Diseases

A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial

J Allergy Clin Immunol

Demoly P, Corren J, Creticos P, De Blay F, Gevaert P, Hellings P, Kowal K, Le Gall M, Nenasheva N, Passalacqua G, Pfaar O, Tortajada-Girbés M, Vidal C, Worm M, Casale TB

doi: 10.1016/j.jaci.2020.07.036

Allergic Diseases

A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial

J Allergy Clin Immunol.

Demoly P, Corren J, Creticos P, De Blay F, Gevaert P, Hellings P, Kowal K, Le Gall M, Nenasheva N, Passalacqua G, Pfaar O, Tortajada-Girbés M, Vidal C, Worm M, Casale TB

doi: 10.1016/j.jaci.

RECOMMENDED

Allergic Diseases

Targeting IgE in allergic disease

doi: 10.1016/j.coi.

Demodex mites modulate sebocyte immune reaction: Possible role in the pathogenesis of rosacea

Br J Dermatol.

Lacey N, Russell-Hallinan A, Zouboulis CC, Powell FC

doi: 10.1111/bjd.16540.

Immunotherapy

Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy

Clin Rev Allergy Immunol.

Scurlock AM

doi: 10.1007/

Atopic Dermatitis

Sensitisation to outdoor and indoor fungi in atopic dermatitis patients and the relation to the occurrence of food allergy to peanuts and walnuts

Mycoses.

Čelakovská J, Bukač J, Ettler K, Vaneckova J, Ettlerova K, Krejsek J

doi: 10.1111/myc.12795.

Related content

Comparison of bronchial and nasal allergen provocation in children and adolescents with bronchial asthma and house dust mite sensitization

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens

Der p 1-specific regulatory T cell response during house dust mite allergen immunotherapy

A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial

A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial

Targeting IgE in allergic disease

Demodex mites modulate sebocyte immune reaction: Possible role in the pathogenesis of rosacea

Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy

Sensitisation to outdoor and indoor fungi in atopic dermatitis patients and the relation to the occurrence of food allergy to peanuts and walnuts